Cerebral arteriosclerosis

WikiDoc Resources for Cerebral arteriosclerosis

Articles

Most recent articles on Cerebral arteriosclerosis

Most cited articles on Cerebral arteriosclerosis

Review articles on Cerebral arteriosclerosis

Articles on Cerebral arteriosclerosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cerebral arteriosclerosis

Images of Cerebral arteriosclerosis

Photos of Cerebral arteriosclerosis

Podcasts & MP3s on Cerebral arteriosclerosis

Videos on Cerebral arteriosclerosis

Evidence Based Medicine

Cochrane Collaboration on Cerebral arteriosclerosis

Bandolier on Cerebral arteriosclerosis

TRIP on Cerebral arteriosclerosis

Clinical Trials

Ongoing Trials on Cerebral arteriosclerosis at Clinical Trials.gov

Trial results on Cerebral arteriosclerosis

Clinical Trials on Cerebral arteriosclerosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cerebral arteriosclerosis

NICE Guidance on Cerebral arteriosclerosis

NHS PRODIGY Guidance

FDA on Cerebral arteriosclerosis

CDC on Cerebral arteriosclerosis

Books

Books on Cerebral arteriosclerosis

News

Cerebral arteriosclerosis in the news

Be alerted to news on Cerebral arteriosclerosis

News trends on Cerebral arteriosclerosis

Commentary

Blogs on Cerebral arteriosclerosis

Definitions

Definitions of Cerebral arteriosclerosis

Patient Resources / Community

Patient resources on Cerebral arteriosclerosis

Discussion groups on Cerebral arteriosclerosis

Patient Handouts on Cerebral arteriosclerosis

Directions to Hospitals Treating Cerebral arteriosclerosis

Risk calculators and risk factors for Cerebral arteriosclerosis

Healthcare Provider Resources

Symptoms of Cerebral arteriosclerosis

Causes & Risk Factors for Cerebral arteriosclerosis

Diagnostic studies for Cerebral arteriosclerosis

Treatment of Cerebral arteriosclerosis

Continuing Medical Education (CME)

CME Programs on Cerebral arteriosclerosis

International

Cerebral arteriosclerosis en Espanol

Cerebral arteriosclerosis en Francais

Business

Cerebral arteriosclerosis in the Marketplace

Patents on Cerebral arteriosclerosis

Experimental / Informatics

List of terms related to Cerebral arteriosclerosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Apoorva Kondapally​

Synonyms and keywords:

## Special consideration when adding information from observational studies[edit | edit source]

Template Sentence for Observational Study

“Among (number of/other important demographic information) patients in (location), (exposure) was associated with (outcome) in observational data” (REF)
Example:

* Among 459 adult male diabetic patients in the United States, COVID-19 exposure was associated with abdominal pain in observational data (REF)

## Overview[edit | edit source]

## Historical Perspective[edit | edit source]

[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].

The association between [important risk factor/cause] and [disease name] was made in/during [year/event].

In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].

In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

There have been several outbreaks of [disease name], including 
--.

In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

## Classification[edit | edit source]

There is no established system for the classification of [disease name].

[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

The staging of [malignancy name] is based on the [staging system].

There is no established system for the staging of [malignancy name].

## Pathophysiology[edit | edit source]

The pathophysiology of cerebral arteriosclerosis is almost similar to the arteriosclerosis in other regions of the vascular system with minor differences. [1]

It is a gradually progressing disease, initiated by the stiffening of cerebral blood vessels due to increased collagen and fibrosis in tunica media and tunica intima majorly due to aging. This combined with chronic injury to endothelium due to conventional risk factors like hypertension, hyperlipidemia, smoking will lead to endothelial dysfunction, macrophage activation, smooth muscle proliferation. All these pathological processes cause the accumulation of lipids and the formation of atherosclerotic plaques. [2] The slow expansion of these plaques or the occasional rapid expansion due to thrombus aggregate from small plaque rupture can lead to occlusion of these vessels and obstructs the free flow of blood to the brain. Large cerebral vessel occlusion by these plaques can result in stroke and small-vessel occlusion can cause vascular dementia. [3]

## Causes[edit | edit source]

Disease name] may be caused by [cause1], [cause2], or [cause3].

Common causes of [disease] include [cause1], [cause2], and [cause3].

The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].

The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.

## Differentiating ((Page name)) from other Diseases[edit | edit source]

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

## Epidemiology and Demographics[edit | edit source]

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.

Patients of all age groups may develop [disease name].

The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

[Disease name] commonly affects individuals younger than/older than [number of years] years of age.

[Chronic disease name] is usually first diagnosed among [age group].

[Acute disease name] commonly affects [age group].

There is no racial predilection to [disease name].

[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

[Disease name] affects men and women equally.

[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

The majority of [disease name] cases are reported in [geographical region].

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

## Risk Factors[edit | edit source]

There are no established risk factors for [disease name].

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

## Screening[edit | edit source]

There is insufficient evidence to recommend routine screening for [disease/malignancy].

According to the [guideline name], screening for [disease name] is not recommended.

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

## Natural History, Complications, and Prognosis[edit | edit source]

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

## Diagnosis[edit | edit source]

### Diagnostic Study of Choice[edit | edit source]

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

There are no established criteria for the diagnosis of [disease name].

### History and Symptoms[edit | edit source]

The majority of patients with [disease name] are asymptomatic.

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

### Physical Examination[edit | edit source]

Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].

Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].

The presence of [finding(s)] on physical examination is diagnostic of [disease name].

The presence of [finding(s)] on physical examination is highly suggestive of [disease name].

### Laboratory Findings[edit | edit source]

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

[Test] is usually normal among patients with [disease name].

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

There are no diagnostic laboratory findings associated with [disease name].

### Electrocardiogram[edit | edit source]

There are no ECG findings associated with [disease name].

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

### X-ray[edit | edit source]

There are no x-ray findings associated with [disease name].

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

### Echocardiography or Ultrasound[edit | edit source]

There are no echocardiography/ultrasound findings associated with [disease name].

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

### CT scan[edit | edit source]

There are no CT scan findings associated with [disease name].

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

### MRI[edit | edit source]

There are no MRI findings associated with [disease name].

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

### Other Imaging Findings[edit | edit source]

There are no other imaging findings associated with [disease name].

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

### Other Diagnostic Studies[edit | edit source]

There are no other diagnostic studies associated with [disease name].

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

## Treatment[edit | edit source]

### Medical Therapy[edit | edit source]

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

The majority of cases of [disease name] are self-limited and require only supportive care.

[Disease name] is a medical emergency and requires prompt treatment.

The mainstay of treatment for [disease name] is [therapy].

OR  The optimal therapy for [malignancy name] depends on the stage at diagnosis.

[Therapy] is recommended among all patients who develop [disease name].

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

### Surgery[edit | edit source]

Surgical intervention is not recommended for the management of [disease name].

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

Surgery is the mainstay of treatment for [disease or malignancy].

### Primary Prevention[edit | edit source]

There are no established measures for the primary prevention of [disease name].

There are no available vaccines against [disease name].

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

### Secondary Prevention[edit | edit source]

There are no established measures for the secondary prevention of [disease name].

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

## References[edit | edit source]

1. ↑ Moossy, J. (1977). "Cerebral Atherosclerosis: Morphology and Some Relationships with Coronary Atherosclerosis": 253–260. doi:10.1007/978-3-642-66662-9_24.
2. ↑ Chen XY, Fisher M (2016). "Pathological Characteristics". Front Neurol Neurosci. 40: 21–33. doi:10.1159/000448267. PMC 6048595. PMID 27960191.
3. ↑ Weller, R.O.; Carare, R.O.; Boche, D. (2009). "Amyloid: Vascular and Parenchymal": 355–362. doi:10.1016/B978-008045046-9.00105-4.

Template:WikiDoc Sources